Utility of EGFR and PTEN numerical aberrations in the evaluation of diffusely infiltrating astrocytomas Laboratory investigation

Journal of Neurosurgery

Volumn 108, Issue 2, 2008, Pages 330-335

  Mott, Ryan T ^a   Turner, Kristi C ^b   Bigner, Darell D ^b   McLendon, Roger E ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidermal growth factor receptor; Fluorescence in situ hybridization; Infiltrating astrocytoma; Phosphatase and tensin homolog

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CARCINOGENESIS; CENTROMERE; CHROMOSOME 10; CHROMOSOME 7; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE LOCUS; GLIOBLASTOMA; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MONOSOMY; PHOSPHATASE AND TENSIN HOMOLOG GENE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CELL; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; ANEUPLOIDY; ASTROCYTOMA; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 7; DISEASE PROGRESSION; GENES, ERBB-1; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MODELS, BIOLOGICAL; MONOSOMY; PTEN PHOSPHOHYDROLASE; SURVIVAL RATE;

EID: 38949147093     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS/2008/108/2/0330     Document Type: Article

References (28)

1. Burger PC, Vogel FS, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111, 1985
2. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, et al: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52:997-1007, 1983
3. Dalrymple SJ, Herath JF, Ritland SR, Moertel CA, Jenkins RB: Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas. J Neurosurg 83:316-323, 1995
4. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152-2165, 1988
5. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP: Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51:2164-2172, 1991
6. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, et al: Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9:2313-2320, 1994
7. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C: PI3K/Akt and apoptosis: size matters. Oncogene 22:8983-8998, 2003
8. Fuller CE, Perry A: Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology. Brain Pathol 12:67-86, 2002
9. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, et al: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 36:714-721, 1994
10. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J: Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 51:84-90, 1992
11. Ichimura K, Ohgaki H, Kleihues P, Collins VP: Molecular pathogenesis of astrocytic tumours. J Neurooncol 70:137-160, 2004
12. Jukich PJ, McCarthy BJ, Surawicz TS, Freels S, Davis FG: Trends in incidence of primary brain tumors in the United States, 1985-1994. Neuro Oncol 3:141-151, 2001
13. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K: Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 74:27-37, 1991
14. Kleihues P, Cavenee WK: Pathology and Genetics of Tumours of the Nervous System, ed 2. Lyon: IARC Press, 2000
15. Li DM, Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57:2124-2129, 1997
16. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947, 1997
17. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, et al: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313:144-147, 1985
18. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378, 1998
19. Narita Y, Nagane M, Mishima K, Huang HJ, Furnari FB, Cavenee WK: Mutant epidermal growth factor receptor signaling downregulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res 62:6764-6769, 2002
20. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, et al: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci U S A 91:7727-7731, 1994
21. Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, et al: Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Neuro Oncol 1:124-137, 1999
22. Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, et al: Alterations of the TP53 gene in human gliomas. Cancer Res 54:1324-1330, 1994
23. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, et al: PTEN gene mutations are seen in highgrade but not in low-grade gliomas. Cancer Res 57:4187-4190, 1997
24. Reifenberger G, Collins VP: Pathology and molecular genetics of astrocytic gliomas. J Mol Med 82:656-670, 2004
25. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846-847, 1992
26. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO: Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 61:6674-6678, 2001
27. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362, 1997
28. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A 84:6899-6903, 1987